Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SURPH: AG-86893 for Pterygium
NCT03533244Phase 2Completed
- Sponsor
- Allgenesis Biotherapeutics
- Start
- Oct 2018
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AG-86893 in pterygium, sponsored by Allgenesis Biotherapeutics. Started Oct 2018; status: completed.
02
Drugs
AG-86893
03
Conditions
pterygium
Beyond the preview
Go deeper on NCT03533244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03533244.